EMA Opinion under re-examination: Iloperidone Vanda Pharmaceuticals (iloperidone) — Vanda Pharmaceuticals Netherlands B.V.

View source ↗

Summary

EMA has issued an opinion under re-examination for iloperidone by Vanda Pharmaceuticals Netherlands B.V. for schizophrenia and bipolar disorder, with a decision…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Iloperidone (iloperidone)

Snippet

Status: Opinion under re-examination. Therapeutic area: Schizophrenia;Bipolar Disorder. MAH: Vanda Pharmaceuticals Netherlands B.V.. Decision date: 26/02/2026